NCT06015334

Brief Summary

The proposed randomized clinical trial aims to compare visual performance, measured using VR simulations, in cataract patients implanted either with bilateral trifocal IOL or bilateral monofocal IOL with monovision. The hypothesis is that patients implanted with trifocal IOL would exhibit superior visual performance, in both daytime and nighttime conditions, compared to those with a monofocal IOL with monovision.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
114

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Oct 2023

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 23, 2023

Completed
6 days until next milestone

First Posted

Study publicly available on registry

August 29, 2023

Completed
1 month until next milestone

Study Start

First participant enrolled

October 1, 2023

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2024

Completed
Last Updated

August 29, 2023

Status Verified

August 1, 2023

Enrollment Period

1 year

First QC Date

August 23, 2023

Last Update Submit

August 23, 2023

Conditions

Keywords

cataractvirtual realitymultifocal intraocular lenstrifocal intraocular lensmonovision

Outcome Measures

Primary Outcomes (1)

  • Overall Virtual reality (VR) performance score

    VR performance score measured from all VR simulations

    Pre-operation, Month3

Secondary Outcomes (9)

  • Task-specific VR performance score

    Pre-operation, Month3

  • Binocular reading speed assessment

    Pre-operation, Month3

  • Binocular contrast sensitivity

    Pre-operation, Month3

  • Distance visual acuity

    Pre-operation, Day1, Week1, Month1, Month3

  • Intermediate (66 cm) visual acuity

    Month3

  • +4 more secondary outcomes

Study Arms (2)

Bilateral implantation of trifocal intraocular lens

ACTIVE COMPARATOR

Patients will receive bilateral implantation of TECNIS Synergy intraocular lens

Procedure: cataract surgery with implantation of intraocular lens

Bilateral monofocal intraocular lens implantation with monovision

ACTIVE COMPARATOR

Patients will receive bilateral implantation of TECNIS monofocal intraocular lens

Procedure: cataract surgery with implantation of intraocular lens

Interventions

Cataract surgery with implantation of bilateral trifocal IOL (TECNIS Synergy) implantation or bilateral monofocal IOL (Tecnis monofocal) with monovision.

Bilateral implantation of trifocal intraocular lensBilateral monofocal intraocular lens implantation with monovision

Eligibility Criteria

Age35 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Bilateral cataract
  • Regular corneal astigmatism
  • Corneal endothelium cell count \>2000 cells/mm2
  • Clear intraocular media other than cataract

You may not qualify if:

  • Concomitant ocular diseases
  • Irregular corneal aberration
  • Capsular instability
  • Systemic disease that may affect vision
  • History of other intraocular surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (12)

  • Zhang F, Sugar A, Jacobsen G, Collins M. Visual function and spectacle independence after cataract surgery: bilateral diffractive multifocal intraocular lenses versus monovision pseudophakia. J Cataract Refract Surg. 2011 May;37(5):853-8. doi: 10.1016/j.jcrs.2010.12.041.

    PMID: 21511153BACKGROUND
  • Mahrous A, Ciralsky JB, Lai EC. Revisiting monovision for presbyopia. Curr Opin Ophthalmol. 2018 Jul;29(4):313-317. doi: 10.1097/ICU.0000000000000487.

    PMID: 29708928BACKGROUND
  • Chen M, Atebara NH, Chen TT. A comparison of a monofocal Acrysoft IOL using the "blended monovision" formula with the multifocal array IOL for glasses independence after cataract surgery. Ann Ophthalmol (Skokie). 2007 Fall;39(3):237-40. doi: 10.1007/s12009-007-0035-4.

    PMID: 18025632BACKGROUND
  • Goldberg DG, Goldberg MH, Shah R, Meagher JN, Ailani H. Pseudophakic mini-monovision: high patient satisfaction, reduced spectacle dependence, and low cost. BMC Ophthalmol. 2018 Nov 9;18(1):293. doi: 10.1186/s12886-018-0963-3.

    PMID: 30413145BACKGROUND
  • Smith CE, Allison RS, Wilkinson F, Wilcox LM. Monovision: Consequences for depth perception from large disparities. Exp Eye Res. 2019 Jun;183:62-67. doi: 10.1016/j.exer.2018.09.005. Epub 2018 Sep 17.

    PMID: 30237103BACKGROUND
  • Lam AKN, To E, Weinreb RN, Yu M, Mak H, Lai G, Chiu V, Wu K, Zhang X, Cheng TPH, Guo PY, Leung CKS. Use of Virtual Reality Simulation to Identify Vision-Related Disability in Patients With Glaucoma. JAMA Ophthalmol. 2020 May 1;138(5):490-498. doi: 10.1001/jamaophthalmol.2020.0392.

    PMID: 32191274BACKGROUND
  • Dick HB, Ang RE, Corbett D, Hoffmann P, Tetz M, Villarrubia A, Palomino C, Castillo-Gomez A, Tsai L, Thomas EK, Janakiraman P. Comparison of 3-month visual outcomes of a new multifocal intraocular lens vs a trifocal intraocular lens. J Cataract Refract Surg. 2022 Nov 1;48(11):1270-1276. doi: 10.1097/j.jcrs.0000000000000971. Epub 2022 May 12.

    PMID: 35545816BACKGROUND
  • Ferreira TB, Ribeiro FJ, Silva D, Matos AC, Gaspar S, Almeida S. Comparison of refractive and visual outcomes of 3 presbyopia-correcting intraocular lenses. J Cataract Refract Surg. 2022 Mar 1;48(3):280-287. doi: 10.1097/j.jcrs.0000000000000743.

    PMID: 34321410BACKGROUND
  • Ramulu PY, Swenor BK, Jefferys JL, Rubin GS. Description and validation of a test to evaluate sustained silent reading. Invest Ophthalmol Vis Sci. 2013 Jan 23;54(1):673-80. doi: 10.1167/iovs.12-10617.

    PMID: 23258146BACKGROUND
  • Mangione CM, Lee PP, Gutierrez PR, Spritzer K, Berry S, Hays RD; National Eye Institute Visual Function Questionnaire Field Test Investigators. Development of the 25-item National Eye Institute Visual Function Questionnaire. Arch Ophthalmol. 2001 Jul;119(7):1050-8. doi: 10.1001/archopht.119.7.1050.

    PMID: 11448327BACKGROUND
  • Mangione CM, Lee PP, Pitts J, Gutierrez P, Berry S, Hays RD. Psychometric properties of the National Eye Institute Visual Function Questionnaire (NEI-VFQ). NEI-VFQ Field Test Investigators. Arch Ophthalmol. 1998 Nov;116(11):1496-504. doi: 10.1001/archopht.116.11.1496.

    PMID: 9823352BACKGROUND
  • Petrillo J, Cano SJ, McLeod LD, Coon CD. Using classical test theory, item response theory, and Rasch measurement theory to evaluate patient-reported outcome measures: a comparison of worked examples. Value Health. 2015 Jan;18(1):25-34. doi: 10.1016/j.jval.2014.10.005.

    PMID: 25595231BACKGROUND

Related Links

MeSH Terms

Conditions

Cataract

Interventions

Cataract ExtractionLens Implantation, Intraocular

Condition Hierarchy (Ancestors)

Lens DiseasesEye Diseases

Intervention Hierarchy (Ancestors)

Refractive Surgical ProceduresOphthalmologic Surgical ProceduresSurgical Procedures, Operative

Study Officials

  • Christopher Leung, MD, MB ChB

    The University of Hong Kong

    PRINCIPAL INVESTIGATOR

Central Study Contacts

ChristopherAnita Yau

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
Patients will remain unaware of their specific study arm assignments until the completion of the study.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Patients with cataract will receive implantation of bilateral trifocal IOL (TECNIS Synergy) implantation or bilateral monofocal IOL (Tecnis monofocal) with monovision.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Professor

Study Record Dates

First Submitted

August 23, 2023

First Posted

August 29, 2023

Study Start

October 1, 2023

Primary Completion

September 30, 2024

Study Completion

September 30, 2024

Last Updated

August 29, 2023

Record last verified: 2023-08

Data Sharing

IPD Sharing
Will not share

Our plan is focused on publishing the analyzed results of our research through peer-review, journals and conference papers. We understand the importance of patient privacy and confidentiality. Therefore, we will not share any individual patient data with any third parties.